183 related articles for article (PubMed ID: 34273518)
1. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
Lalwani P; Salgado BB; Filho IVP; da Silva DSS; de Morais TBDN; Jordão MF; Barbosa ARC; Cordeiro IB; Neto JNS; de Assunção EN; Dos Santos RO; Carvalho NO; Sobrinho WBS; da Costa CF; de Souza PE; de Albuquerque BC; Ganoza CA; Araujo-Castillo RV; Filho SA; Lalwani JDB;
Int J Infect Dis; 2021 Sep; 110():141-150. PubMed ID: 34273518
[TBL] [Abstract][Full Text] [Related]
2. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
[TBL] [Abstract][Full Text] [Related]
3. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
[TBL] [Abstract][Full Text] [Related]
7. The seroprevalence of SARS-CoV-2 in a rural southwest community.
Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
[TBL] [Abstract][Full Text] [Related]
8. Migration in times of pandemic: SARS-CoV-2 infection among the Warao indigenous refugees in Belém, Pará, Amazonia, Brazil.
da Silva HP; Abreu IN; Lima CNC; de Lima ACR; do Nascimento Barbosa A; de Oliveira LR; Fujishima MA; Lima SS; de Lima VN; Castelo-Branco S; Vallinoto ACR
BMC Public Health; 2021 Sep; 21(1):1659. PubMed ID: 34511064
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.
Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N;
Front Public Health; 2021; 9():628098. PubMed ID: 34249830
[No Abstract] [Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
[TBL] [Abstract][Full Text] [Related]
12. Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.
Pontes GS; de Melo Silva J; Pinheiro-Silva R; Barbosa AN; Santos LC; de Pádua Quirino Ramalho A; de Castro Alves CE; da Silva DF; de Oliveira LC; da Costa AG; Bruno AC
Sci Rep; 2021 Sep; 11(1):17534. PubMed ID: 34475438
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020.
Khan SMS; Qurieshi MA; Haq I; Majid S; Ahmad J; Ayub T; Bhat AA; Fazili AB; Ganai AM; Jan Y; Kaul RU; Khan ZA; Masoodi MA; Mushtaq B; Nazir F; Nazir M; Raja MW; Rasool M; Asma A; Ayoub S; Aziz M; Bhat AA; Chowdri IN; Ismail S; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Obaid M; Qazi TB; Sabah I; Sumji IA
BMJ Open; 2021 Sep; 11(9):e053791. PubMed ID: 34556519
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
[TBL] [Abstract][Full Text] [Related]
15. Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.
Fofana MO; Nery N; Aguilar Ticona JP; de Andrade Belitardo EMM; Victoriano R; Anjos RO; Portilho MM; de Santana MC; Dos Santos LL; de Oliveira D; Cruz JS; Muenker MC; Khouri R; Wunder EA; Hitchings MDT; Johnson O; Reis MG; Ribeiro GS; Cummings DAT; Costa F; Ko AI
PLoS Med; 2022 Sep; 19(9):e1004093. PubMed ID: 36074784
[TBL] [Abstract][Full Text] [Related]
16. The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study.
Sharma N; Sharma P; Basu S; Saxena S; Chawla R; Dushyant K; Mundeja N; Marak Z; Singh S; Singh G; Rustagi R
Trans R Soc Trop Med Hyg; 2022 Mar; 116(3):242-251. PubMed ID: 34339514
[TBL] [Abstract][Full Text] [Related]
17. Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey.
Valerio-Shewmaker MA; DeSantis S; Swartz M; Yaseen A; Gonzalez MO; Kohl HWI; Kelder SH; Messiah SE; Aguillard KA; Breaux C; Wu L; Shuford J; Pont S; Lakey D; Boerwinkle E
Front Public Health; 2021; 9():753487. PubMed ID: 34970525
[No Abstract] [Full Text] [Related]
18. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
19. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
